Directori de persones
Jose Manuel Valdivielso Revilla

Jose Manuel Valdivielso Revilla

Grau: Doctor/a

973 702 952
valdivielso(ELIMINAR)@irblleida.cat

ResearcherID: https://www.researcherid.com/rid/ABC-4410-2021

OrcidID: https://orcid.org/0000-0003-1343-0184

Grups

Publicacions

  • Serrano, JCE; Castro-Boqué, E; García-Carrasco, A; Morán-Valero, MI; Municio, MD; Bermúdez-López, M; Valdivielso, JM; Espinel, AE; Portero-Otín, M

    Effects of aged black garlic (ABG10+®) on lipoprotein subclass composition in Grade I hypertension: a randomized, triple-blind controlled trial with sex-stratified sequential allocation

    Frontiers in Nutrition 13 -. .

    [doi:10.3389/fnut.2026.1869617]

  • Hernando-Redondo, J; Camps-Vilaró, A; Elosua, R; Fornara, E; Bermúdez-López, M; Torán-Monserrat, P; Jiménez-Navarro, A; Valdivielso, JM; López-Lifante, VM; Salas-Fernández, T; Cambray, S; Cruz, R; Marrugat, J; Hernáez, A

    Leisure-Time Physical Activity on Age-Modelled Trajectories of Body Mass Index and Obesity Risk Throughout Life: Multivariable Regression and Mendelian Randomization Analyses Using Electronic Health Record Data From the CORDELIA-Catalunya Study

    DIABETES OBESITY & METABOLISM -. .

    [doi:10.1111/dom.71090]

  • Izarra, A; Bermúdez-López, M; Valdivielso, JM; Soler, MJ; Pamplona, R; Torres, G; Mauricio, D; Castro-Boqué, E; Fernández, E; Hernández, M; Simó, R; Hernández, C; Lecube, A

    Baseline and Follow-Up Association between Adiposity and Renal Function: Data from the ILERVAS Cohort

    Obesity Facts -. .

    [doi:10.1159/000552362]

  • Neuen, BL; Major, RW; Grams, ME; Sang, YY; Coresh, J; Ballew, SH; Surapaneni, A; de Pinho, NA; Ärnlöv, J; Arnott, C; Bell, S; Berry, J; Brenner, H; Ciemins, E; Chang, AR; Cushman, M; de Lemos, JA; Diaz-Tocados, JM; Farjat, AE; Fletcher, RA; Gansevoort, RT; Heerspink, HJL; Herrington, WG; Hong, C; Horwitz, EJ; Hwang, SJ; Jassal, SK; Kalra, PA; Katz, R; Khan, SS; Kovesdy, CP; Kronenberg, F; Lees, JS; Lloyd-Jones, DM; Mill, JG; Naimark, DMJ; Ndumele, C; Polkinghorne, KR; Psaty, BM; Schloemer, P; Shlipak, MG; Shrestha, P; Song, Z; Staplin, N; Steubl, D; Vart, P; Visseren, FLJ; Woodward, M; Yamagishi, K; Young, BA; Sabanayagam, C; Valdivielso, JM

    Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals

    NATURE MEDICINE 32 2629-2638. .

    [doi:10.1038/s41591-026-04437-z]

  • Izarra, A; Bermúdez-López, M; Valdivielso, JM; Pamplona, R; Torres, G; Mauricio, D; Castro-Boqué, E; Fernández, E; Simó, R; Hernández, C; Lecube, A

    Baseline and 4-year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort

    DIABETES OBESITY & METABOLISM 28 3777-3787. .

    [doi:10.1111/dom.70560]

  • Chinnappa, S; Van Craenenbroeck, AH; Dounousi, E; Fernandez-Fernandez, B; Iatridi, F; Piko, N; Stegbauer, J; Torino, C; Vogt, L; Valdivielso, JM; Mark, PB

    Ten tips to control blood pressure in haemodialysis patients

    Clinical Kidney Journal 19 -. .

    [doi:10.1093/ckj/sfag128]

  • Kanbay, M; Copur, S; Capasso, G; Turkmen, K; Delanaye, P; Bruchfeld, A; Abd ElHafeez, S; Ferro, CJ; Verhaar, MC; Pesce, F; Liakopoulos, V; Boor, P; Adamczak, M; Vivarelli, M; Navarro-González, JF; Kramann, R; Florquin, S; Valdieso, JM

    The evolving field of nephrology: what comes next? A report from the European Renal Association Scientific Advisory Board

    Clinical Kidney Journal 19 -. .

    [doi:10.1093/ckj/sfag136]

  • Agarvas, AR; Sparla, R; Atkins, JL; Altamura, C; Anderson, T; Asicioglu, E; Bassols, J; López-Bermejo, A; Dvoráková, HM; Fernández-Real, JM; Hochmayr, C; Knoflach, M; Milicevic, JK; Lai, SL; Moreno-Navarrete, JM; Pawlak, D; Pawlak, K; Syrovatka, P; Formanowicz, D; Kraml, P; Valdivielso, JM; Valenti, L; Muckenthaler, MU

    Ferritin and transferrin predict common carotid intima-media thickness in females: a machine-learning informed individual participant data meta-analysis

    BMC Cardiovascular Disorders 26 -. .

    [doi:10.1186/s12872-026-05796-8]

  • Bermúdez-López, M; Nogales, P; Martí-Antonio, M; Castro-Boqué, E; De Lamo, VM; Beà-Menchón, L; Luis-Lima, S; Porrini, E; Sanchez-Salguero, X; Jové, M; Obis, E; Mota-Martorell, N; Pérez-Gómez, A; Garcia-Carrasco, A; Bozic, M; Guajardo, J; Pérez-Sánchez, CJ; Cambray, S; Amigó, N; Pamplona, R; Bentzon, JF; Valdivielso, JM

    Chronic kidney disease induces a distinct lipidomic signature and accelerates atherosclerosis progression in a novel minipig model

    Laboratory Animal Research 42 -. .

    [doi:10.1186/s42826-026-00274-w]

  • Zoccali, C; Valdivielso, JM; Vogt, L; Ntounousi, E; Iatridi, F; Piko, N; Fernández-Fernández, B; Ortiz, A; Chinnappa, S; Mark, PB; Kanbay, M; Mallamaci, F; Wiecek, A; Bussolati, B; Bijkerk, R

    Kidney-heart crosstalk: the extracellular vesicles connection

    NEPHROLOGY DIALYSIS TRANSPLANTATION -. .

    [doi:10.1093/ndt/gfag022]

  • Torres, G; Gracia-Lavedan, E; González, J; Henríquez-Beltrán, M; Targa, ADS; Royo, M; Bermúdez-López, M; Castro-Boqué, E; Valdivielso, JM; Pamplona, R; Mauricio, D; Lecube, A; Barbé, F; De Batlle, J; Miquel, E; Ortega, M; Portero-Otín, M; Jové, M; Hernández, M; Rius, F; Franch-Nadal, J; Castelblanco, E; Godoy, P; Martinez-Alonso, M; Simó, R; Hernández, C; Fernández, E

    Skin advanced glycation end-products do not predict pulmonary function trajectories in adults from the ILERVAS cohort

    Scientific Reports 16 3428-3428. .

    [doi:10.1038/s41598-025-33414-8]

  • León-Mengíbar, J; Malagón, MM; Bermúdez-López, M; Valdivielso, JM; Pamplona, R; Torres, G; Mauricio, D; Castro, E; Fernández, E; Caixàs, A; Hernández, M; Lopez-Cano, C; Gordon, A; Guzman-Ruiz, R; Cusi, K; Lecube, A

    Association of estimated liver fibrosis with carotid but not femoral atherosclerotic burden: the ILERVAS cohort

    Frontiers in Endocrinology 16 1651689-1651689. .

    [doi:10.3389/fendo.2025.1651689]

Projectes

  • Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
  • Acciones de Dinamización "Europa Investigación 2020"
  • Contratos Sara Borrell
  • Identification and Management of Patients at Risk – Outcome and Vascular Events in Peritoneal Dialysis
  • Papel de la vía PI3K/AKT/mTOR en la regulación de las alteraciones del metabolismo mineral en la enfermedad renal crónica. Implicaciones en la regulación de la síntesis de FGF23.
  • Ajuts destinats a contractar personal investigador novell (FI)
  • Ayudas Juan de la Cierva-formación
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA CIENTIFICA BASICA PER A LA CARACTERITZACIO D'UN PERFIL LIPIDOMICO Y LIPIDICO DE RIESGO ATEROGENERICO Y DE MORBIMORTALIDAD CARDIOVASCUAL EN LA ENFERMEDAD RENAL CRONICA (ESTADIOS 3 A 5), ESTUDIO PROSPECTIVO NEFRONA.
  • Caracterización de un perfil lipidomico y lipídico de riesgo aterogénico y de morbimortalidad cardiovascular en la enfermedad renal crónica (estadios 3 a 5) (estudio prospectivo NEFRONA)
  • ADVENTITIAL VASA VASORUM AND SUBCLINICAL ATHEROMATOSIS
  • Papel de la expresión renal de alfa sinucleina en la enfermedad renal crónica. Implicaciones en la patogénesis de la fibrosis renal
  • IDENTIFYING PREDICTORS OF CARDIOVASCULAR EVENTS IN CHRONIC KIDNEY DISEASE. A COHORTS SUBSTUDY WITHIN THE NEFRONA STUDY